217 related articles for article (PubMed ID: 7046899)
1. Combination chemotherapy with cyclophosphamide, vincristine, prednisone and the contribution of adriamycin in the treatment of adult non-Hodgkin's lymphomas a report of 131 cases.
Parlier Y; Gorin NC; Najman A; Stachowiak J; Duhamel G
Cancer; 1982 Aug; 50(3):401-9. PubMed ID: 7046899
[TBL] [Abstract][Full Text] [Related]
2. [Adriamycin for the treatment of non HOdgkin's lymphomas (author's transl)].
Parlier Y; Gorin NC; Stachowiak J; Najman A; Duhamel G
Sem Hop; 1981 Nov 8-25; 57(41-42):1685-90. PubMed ID: 6272402
[TBL] [Abstract][Full Text] [Related]
3. Combination of cyclophosphamide, vincristine, and prednisone, followed by maintenance chemotherapy, with and without radiotherapy, in the management of patients with non-Hodgkin's lymphomas.
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Med Pediatr Oncol; 1977; 3(1):41-51. PubMed ID: 320448
[TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy with cyclophosphamide, vincristine, and prednisone in advanced non-Hodgkin's lymphomas.
Portlock CS; Rosenberg SA
Cancer; 1976 Mar; 37(3):1275-82. PubMed ID: 1260652
[TBL] [Abstract][Full Text] [Related]
5. Cyclophosphamide, vincristine, and prednisone (CVP) versus adriamycin, bleomycin, and prednisone (ABP) in stage IV non-Hodgkin's lymphomas.
Monfardini S; Tancini G; DeLena M; Villa E; Valagussa P; Bonadonna G
Med Pediatr Oncol; 1977; 3(1):67-74. PubMed ID: 65728
[TBL] [Abstract][Full Text] [Related]
6. Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata.
Bonadonna G; De Lena M; Lattuada A; Milani F; Monfardini S; Beretta G
Br J Cancer Suppl; 1975 Mar; 2():481-8. PubMed ID: 52367
[TBL] [Abstract][Full Text] [Related]
7. [Cyclophosphamide-vincristine-prednisone combination in the treatment of lympho- and reticulosarcomas in adults (60 cases)].
Gorin NC; David R; Stachowiak J; Najman A; Duhamel G
Nouv Presse Med; 1976 Nov; 5(38):2525-30. PubMed ID: 790316
[TBL] [Abstract][Full Text] [Related]
8. Non-cross-resistant combinations in stage IV non-Hodgkin's lymphomas.
Bonadonna G; Monfardini S; Villa E
Cancer Treat Rep; 1977 Sep; 61(6):1117-23. PubMed ID: 71209
[TBL] [Abstract][Full Text] [Related]
9. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
[TBL] [Abstract][Full Text] [Related]
10. Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma.
Schein PS; DeVita VT; Hubbard S; Chabner BA; Canellos GP; Berard C; Young RC
Ann Intern Med; 1976 Oct; 85(4):417-22. PubMed ID: 61732
[TBL] [Abstract][Full Text] [Related]
11. Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
Klasa RJ; Meyer RM; Shustik C; Sawka CA; Smith A; Guévin R; Maksymiuk A; Rubinger M; Samosh M; Laplante S; Grenier JF
J Clin Oncol; 2002 Dec; 20(24):4649-54. PubMed ID: 12488409
[TBL] [Abstract][Full Text] [Related]
12. Prednimustine v cyclophosphamide-vincristine-prednisolone in the treatment of non-Hodgkin's lymphoma with favorable histopathology: results of a national cancer care program in Sweden.
Cavallin-Ståhl E; Möller TR
Semin Oncol; 1986 Mar; 13(1 Suppl 1):19-22. PubMed ID: 3952518
[TBL] [Abstract][Full Text] [Related]
13. Chemotherapy of non-Hodgkin's lymphomas: Eastern Cooperative Oncology Group experience.
Bennett JM; Lenhard RE; Ezdinli E; Johnson GJ; Carbone PP; Pocock SJ
Cancer Treat Rep; 1977 Sep; 61(6):1079-83. PubMed ID: 71207
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary results.
Comella P; Abate G; Comella G; Bruni GS; Zarrilli D; Pergola M
Tumori; 1980 Dec; 66(6):749-56. PubMed ID: 7233568
[TBL] [Abstract][Full Text] [Related]
15. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
[TBL] [Abstract][Full Text] [Related]
16. The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
Weick JK; Antunez A; Kraus TA; Fabian CJ; Dixon D
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1205-7. PubMed ID: 6347997
[TBL] [Abstract][Full Text] [Related]
17. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
[TBL] [Abstract][Full Text] [Related]
18. NHL-3 protocol. Six-drug combination chemotherapy for non-Hodgkin's lymphoma.
Koziner B; Sklaroff R; Little C; Labriola D; Thaler HT; Straus DJ; Young CW; Nisce LZ; Oettgen H; Lee BJ
Cancer; 1984 Jun; 53(12):2592-600. PubMed ID: 6547072
[TBL] [Abstract][Full Text] [Related]
19. VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas.
Hansen MM; Bloomfield CD; Jørgensen J; Ersbøll J; Pedersen-Bjergaard J; Blom J; Nissen NI
Cancer Treat Rep; 1980; 64(10-11):1135-7. PubMed ID: 7459900
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy of advanced non-Hodgkin lymphoma with bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP).
Skarin AT; Rosenthal DS; Moloney WC; Frei E
Blood; 1977 May; 49(5):759-70. PubMed ID: 66957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]